Hepatitis B Vaccines

BIOLOGICAL4 trials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI), Cytuvax BV, Center for Genetic Engineering and Biothecnology (CIGB), in Havana., Center for Genetic Engineering and Biotechnology (CIGB), in Havana.

Conditions

Hepatitis BHepatitis B (Prevention).Hepatitis B vaccine for non-respondersHepatitis, Viral, HumanLiver DiseasesProphylaxis of Hepatitis B virus infection.

Phase 3

Hepatitis B Vaccine Clinical Trial

CompletedNCT00000583

National Heart, Lung, and Blood Institute (NHLBI)Hepatitis B, Hepatitis, Viral, Human, Liver Diseases

Start: 1978-11-30End: 1980-06-30Updated: 2013-11-26

Phase 4

Safety and immunogenicity of commercial Hepatitis B vaccines.

Active, not recruitingRPCEC00000031

Center for Genetic Engineering and Biothecnology (CIGB), in Havana.Hepatitis B (Prevention).

Start: 2004-03-31Target: 400Updated: 2026-03-30

HEBERBIOVAC HB vaccine to reference material.

Active, not recruitingRPCEC00000244

Center for Genetic Engineering and Biotechnology (CIGB), in Havana.Prophylaxis of Hepatitis B virus infection.

Start: 2017-07-01Target: 190Updated: 2026-03-30

Unknown Phase

Safety and immunogenicity of HBAI20 adjuvanted Hepatitis B vaccine in naive adults and non-responders

Active, not recruitingNL-OMON41999

Cytuvax BVHepatitis B vaccine for non-responders

Start: 2017-10-11Target: 36Updated: 2024-02-28